297 related articles for article (PubMed ID: 30565250)
1. Insights into immunity from clinical and basic science studies of DOCK8 immunodeficiency syndrome.
Su HC; Jing H; Angelus P; Freeman AF
Immunol Rev; 2019 Jan; 287(1):9-19. PubMed ID: 30565250
[TBL] [Abstract][Full Text] [Related]
2. [Combined immunodeficiency due to DOCK8 deficiency. State of the art].
Liquidano-Pérez E; Maza-Ramos G; Yamazaki-Nakashimada MA; Barragán-Arévalo T; Lugo-Reyes SO; Scheffler-Mendoza S; Espinosa-Padilla SE; González-Serrano ME
Rev Alerg Mex; 2022 Jul; 69(1):31-47. PubMed ID: 36927749
[TBL] [Abstract][Full Text] [Related]
3. Recent Advances in DOCK8 Immunodeficiency Syndrome.
Zhang Q; Jing H; Su HC
J Clin Immunol; 2016 Jul; 36(5):441-9. PubMed ID: 27207373
[TBL] [Abstract][Full Text] [Related]
4. DOCK8 deficiency: Insights into pathophysiology, clinical features and management.
Biggs CM; Keles S; Chatila TA
Clin Immunol; 2017 Aug; 181():75-82. PubMed ID: 28625885
[TBL] [Abstract][Full Text] [Related]
5. Somatic reversion in dedicator of cytokinesis 8 immunodeficiency modulates disease phenotype.
Jing H; Zhang Q; Zhang Y; Hill BJ; Dove CG; Gelfand EW; Atkinson TP; Uzel G; Matthews HF; Mustillo PJ; Lewis DB; Kavadas FD; Hanson IC; Kumar AR; Geha RS; Douek DC; Holland SM; Freeman AF; Su HC
J Allergy Clin Immunol; 2014 Jun; 133(6):1667-75. PubMed ID: 24797421
[TBL] [Abstract][Full Text] [Related]
6. Lineage-Specific Chimerism and Outcome After Hematopoietic Stem Cell Transplantation for DOCK8 Deficiency.
Raedler J; Magg T; Rohlfs M; Klein C; Vallée T; Hauck F; Albert MH
J Clin Immunol; 2021 Oct; 41(7):1536-1548. PubMed ID: 34080085
[TBL] [Abstract][Full Text] [Related]
7. DOCK8 deficiency.
Su HC; Jing H; Zhang Q
Ann N Y Acad Sci; 2011 Dec; 1246():26-33. PubMed ID: 22236427
[TBL] [Abstract][Full Text] [Related]
8. Clinical, immunologic and genetic profiles of DOCK8-deficient patients in Kuwait.
Al-Herz W; Ragupathy R; Massaad MJ; Al-Attiyah R; Nanda A; Engelhardt KR; Grimbacher B; Notarangelo L; Chatila T; Geha RS
Clin Immunol; 2012 Jun; 143(3):266-72. PubMed ID: 22534316
[TBL] [Abstract][Full Text] [Related]
9. Dedicator of cytokinesis 8-deficient CD4
Tangye SG; Pillay B; Randall KL; Avery DT; Phan TG; Gray P; Ziegler JB; Smart JM; Peake J; Arkwright PD; Hambleton S; Orange J; Goodnow CC; Uzel G; Casanova JL; Lugo Reyes SO; Freeman AF; Su HC; Ma CS
J Allergy Clin Immunol; 2017 Mar; 139(3):933-949. PubMed ID: 27554822
[TBL] [Abstract][Full Text] [Related]
10. Clinical and immunological correction of DOCK8 deficiency by allogeneic hematopoietic stem cell transplantation following a reduced toxicity conditioning regimen.
Boztug H; Karitnig-Weiß C; Ausserer B; Renner ED; Albert MH; Sawalle-Belohradsky J; Belohradsky BH; Mann G; Horcher E; Rümmele-Waibel A; Geyeregger R; Lakatos K; Peters C; Lawitschka A; Matthes-Martin S
Pediatr Hematol Oncol; 2012 Oct; 29(7):585-94. PubMed ID: 22897717
[TBL] [Abstract][Full Text] [Related]
11. Hypomorphic function and somatic reversion of DOCK8 cause combined immunodeficiency without hyper-IgE.
Kienzler AK; van Schouwenburg PA; Taylor J; Marwah I; Sharma RU; Noakes C; Thomson K; Sadler R; Segal S; Ferry B; Taylor JC; Blair E; Chapel H; Patel SY
Clin Immunol; 2016 Feb; 163():17-21. PubMed ID: 26680607
[TBL] [Abstract][Full Text] [Related]
12. Aberrant humoral immune reactivity in DOCK8 deficiency with follicular hyperplasia and nodal plasmacytosis.
aan de Kerk DJ; van Leeuwen EM; Jansen MH; van den Berg JM; Alders M; Vermont CL; van Lier RA; Pals ST; Kuijpers TW
Clin Immunol; 2013 Oct; 149(1):25-31. PubMed ID: 23891736
[TBL] [Abstract][Full Text] [Related]
13. Current Status of Dedicator of Cytokinesis-Associated Immunodeficiency: DOCK8 and DOCK2.
Dimitrova D; Freeman AF
Dermatol Clin; 2017 Jan; 35(1):11-19. PubMed ID: 27890234
[TBL] [Abstract][Full Text] [Related]
14. Hematopoietic stem cell transplantation outcomes for 11 patients with dedicator of cytokinesis 8 deficiency.
Al-Herz W; Chu JI; van der Spek J; Raghupathy R; Massaad MJ; Keles S; Biggs CM; Cockerton L; Chou J; Dbaibo G; Elisofon SA; Hanna-Wakim R; Kim HB; Lehmann LE; McDonald DR; Notarangelo LD; Veys P; Chatila TA; Geha RS; Gaspar HB; Pai SY
J Allergy Clin Immunol; 2016 Sep; 138(3):852-859.e3. PubMed ID: 27130861
[TBL] [Abstract][Full Text] [Related]
15. Flow cytometry biomarkers distinguish DOCK8 deficiency from severe atopic dermatitis.
Janssen E; Tsitsikov E; Al-Herz W; Lefranc G; Megarbane A; Dasouki M; Bonilla FA; Chatila T; Schneider L; Geha RS
Clin Immunol; 2014 Feb; 150(2):220-4. PubMed ID: 24440647
[TBL] [Abstract][Full Text] [Related]
16. Hematopoietic stem cell transplant effectively rescues lymphocyte differentiation and function in DOCK8-deficient patients.
Pillay BA; Avery DT; Smart JM; Cole T; Choo S; Chan D; Gray PE; Frith K; Mitchell R; Phan TG; Wong M; Campbell DE; Hsu P; Ziegler JB; Peake J; Alvaro F; Picard C; Bustamante J; Neven B; Cant AJ; Uzel G; Arkwright PD; Casanova JL; Su HC; Freeman AF; Shah N; Hickstein DD; Tangye SG; Ma CS
JCI Insight; 2019 Apr; 5(11):. PubMed ID: 31021819
[TBL] [Abstract][Full Text] [Related]
17. Atypical Localization of Eczema Discriminates DOCK8 or STAT3 Deficiencies from Atopic Dermatitis.
Kasap N; Kara A; Celik V; Bilgic Eltan S; Akay Haci I; Kose H; Aygun A; Akkelle E; Yakici N; Guner SN; Reisli I; Keles S; Cekic S; Kilic SS; Karaca NE; Gulez N; Genel F; Ozen A; Yucelten AD; Karakoc-Aydiner E; Schmitz-Abe K; Baris S
J Clin Immunol; 2023 Nov; 43(8):1882-1890. PubMed ID: 37507632
[TBL] [Abstract][Full Text] [Related]
18. Hematopoietic Stem Cell Transplantation as Treatment for Patients with DOCK8 Deficiency.
Aydin SE; Freeman AF; Al-Herz W; Al-Mousa HA; Arnaout RK; Aydin RC; Barlogis V; Belohradsky BH; Bonfim C; Bredius RG; Chu JI; Ciocarlie OC; Doğu F; Gaspar HB; Geha RS; Gennery AR; Hauck F; Hawwari A; Hickstein DD; Hoenig M; Ikinciogullari A; Klein C; Kumar A; Ifversen MRS; Matthes S; Metin A; Neven B; Pai SY; Parikh SH; Picard C; Renner ED; Sanal Ö; Schulz AS; Schuster F; Shah NN; Shereck EB; Slatter MA; Su HC; van Montfrans J; Woessmann W; Ziegler JB; Albert MH;
J Allergy Clin Immunol Pract; 2019 Mar; 7(3):848-855. PubMed ID: 30391550
[TBL] [Abstract][Full Text] [Related]
19. Treatment options for DOCK8 deficiency-related severe dermatitis.
Ollech A; Mashiah J; Lev A; Simon AJ; Somech R; Adam E; Barzilai A; Hagin D; Greenberger S
J Dermatol; 2021 Sep; 48(9):1386-1393. PubMed ID: 34043252
[TBL] [Abstract][Full Text] [Related]
20. Atopic dermatitis, STAT3- and DOCK8-hyper-IgE syndromes differ in IgE-based sensitization pattern.
Boos AC; Hagl B; Schlesinger A; Halm BE; Ballenberger N; Pinarci M; Heinz V; Kreilinger D; Spielberger BD; Schimke-Marques LF; Sawalle-Belohradsky J; Belohradsky BH; Przybilla B; Schaub B; Wollenberg A; Renner ED
Allergy; 2014 Jul; 69(7):943-53. PubMed ID: 24898675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
